Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α-Reference-Cited by-同舟云学术

Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α

Published:2014-02-24 Issue:4 Volume:124 Page:1794-1809
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Gritsman Kira,Yuzugullu Haluk,Von Thanh,Yan Howard,Clayton Linda,Fritsch Christine,Maira Sauveur-Michel,Hollingworth Gregory,Choi Christine,Khandan Tulasi,Paktinat Mahnaz,Okabe Rachel O.,Roberts Thomas M.,Zhao Jean J.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference53 articles.

1. The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia

2. Signalling by PI3K isoforms: insights from gene-targeted mice

3. AKT/PKB Signaling: Navigating Downstream

4. High Frequency of Mutations of the PIK3CA Gene in Human Cancers

5. Should individual PI3 kinase isoforms be targeted in cancer?

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel iheyamine A derivative L42 suppresses acute myeloid leukemia via dual regulation of the PI3K/AKT/FOXO3a axis and TNF signaling pathway;Biomedicine & Pharmacotherapy;2024-08

2. Mesenchymal stem cell-derived S100A8 facilitates leukemia stem cell maintenance via TLR4/PI3K/Akt signaling;2024-05-14

3. PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway;Blood;2024-05-09

4. PI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells;Science Advances;2023-02-24

5. Targeted therapy in juvenile myelomonocytic leukemia: Where are we now?;Pediatric Blood & Cancer;2022-09-12